StreetAlpha.app
Home › Stocks › DARE

Dare Bioscience, Inc. (DARE)

$0.41
▼ −9.87%
LAST CLOSE · NOV 20

Dare Bioscience develops women's health drugs and consumer products for areas such as contraception, menopause, and sexual health. It last closed at $0.41 on Nov 20, down 9.87% on the day. The next earnings report for DARE is expected around Thu, Mar 25, 2027, after the close. For the quarter ended Sep 2026, DARE reported EPS of -$0.18 on revenue of $47,628, with revenue up 2005.6% from a year ago. Over its last 8 reports the stock moved an average of 11.7% the session after earnings. Over the last 12 months DARE insiders bought $0 of stock on the open market and sold $382, according to SEC Form 4 filings.

AI Auto Pilots
Is DARE in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold DARE.

Key Stats

Last 12 months
Results
Revenue
$1.4M
Net income
−$10.6M
−749.8% margin
EPS (diluted)
−$0.61
Free cash flow
−$18.1M
−1279.2% margin
Valuation
Market cap
$8.0M
19.7M shares
P/E
–
No P/E while losing money
Price to sales
5.7
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$11.5M
At Sep 30
Shareholder equity
$2.3M
Shares outstanding
19.7M
At Nov 13
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $0$0FY2021FY2022: $10.0M$10.0MFY2022FY2023: $2.8M$2.8MFY2023FY2024: $10K$10KFY2024FY2025: $1.0M$1.0MFY2025

From DARE's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 16). Last 12 months adds up the four latest quarters.

Next report
Mar 25
Estimated date · After the close
Reported EPS
-$0.18
Quarter ended Sep 2026
Year ago EPS
-$0.28
Same quarter last year
Revenue
$47,628
+2005.6% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.65Dec '24Mar 2025: -$0.50Mar '25Jun 2025: -$0.45Jun '25Sep 2025: -$0.28Sep '25Dec 2025: -$0.02Dec '25Mar 2026: -$0.21Mar '26Jun 2026: -$0.20Jun '26Sep 2026: -$0.18Sep '26Latest -$0.18
Revenue by quarter
Mar 2025: $25,427Mar '25Sep 2025: $2,262Sep '25Dec 2025: $1.0MDec '25Mar 2026: $152,455Mar '26Jun 2026: $187,546Jun '26Sep 2026: $47,628Sep '26Latest $47,628
How DARE moved after its last 8 reports
Average move the session after a report ±11.7%
Nov 16, 2026After the close−26.6%
Aug 13, 2026After the close−32.1%
May 14, 2026After the close−24.1%
Mar 26, 2026After the close+2.6%
Nov 13, 2025After the close−1.6%
Aug 14, 2025After the close+6.3%
May 13, 2025After the close0.0%
Mar 31, 2025After the close+0.3%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on DAREStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on DARE
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on DARE

Technical Analysis

DARE · as of the Nov 20 close · updated each morning
Downtrend, oversold

The stock is 51% below its 20 day and 73% below its 50 day average. It is 264% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 24), oversold. The nearest support is the Pivot S1 at $0.38, and the nearest resistance the 52 week low at $0.41.

Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 15.8%/day
Key levels
$3.7852 week high+822.0%
$1.48200 day average+261.0%
$0.98100 day average+139.0%
$0.71Swing high (Nov 11)+73.2%
$0.7050 day average+70.7%
$0.6120 day average+48.8%
$0.46Pivot R1+12.2%
$0.43Pivot+4.9%
$0.4152 week low+0.0%
$0.41Last close
$0.38Pivot S1−7.3%
Indicators
RSI (14)23.77Oversold below 30Oversold
MACD-0.07Below its signal lineBearish
Stochastic7.6Near the bottom of its rangeOversold
ADX (14)30.4Trending down
Williams %R-99.5Oversold below −80, overbought above −20Oversold
CCI (20)-190.4Oversold below −100, overbought above 100Oversold
Rate of change−36.2%Change over 10 sessionsBearish
ATR (14)$0.06Typical daily range, 15.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for DARE

What happened before

See how DARE did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow DARE usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How DARE has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2014.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for DAREHow many large options trades hit DARE, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

DARE Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲20 buying vs 9 selling
  • ▲Held by funds +2.2 pts
  • ▲Funds holding +10
  • ▲Superinvestors: 1 added, 0 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding3727+37.0%
In funds' top 1000–
Held by funds8.9%6.6%+2.2 pts
New / increased14 / 67 / 11+11.1%
Reduced / sold out5 / 44 / 50.0%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See DARE institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

DARE Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$3821 sale · 1 insider
2026-11 sold $382DecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 19William H RastetterDirectorSale859$0.45$382
Every insider buy and sale for DARE over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See DARE insider trades →

From SEC Form 4 filings by DARE's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether DARE is in one of them and how their past DARE trades turned out.

DARE in the AI portfolios
Loading…

DARE News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered DARE in an article yet. Here's the latest on the wider market.

DARE in the news

About Dare Bioscience

Dare Bioscience is a biotech company based in San Diego, California, that develops products for women's health. Its portfolio covers areas such as contraception, menopause, sexual health, pelvic pain, fertility, and vaginal health. The company plans to offer prescription products, compounded drugs, and consumer health products that do not need a prescription, mainly for women and the healthcare providers who treat them. Its first FDA-approved product, a treatment for bacterial vaginosis, is licensed to another drugmaker for sale.

Headquarters
San Diego, CA